Clinical Trials Directory

Trials / Sponsors / Annexon, Inc.

Annexon, Inc.

Industry · 15 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingAn Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Gui
Guillain-Barre Syndrome
Phase 32025-09-12
Active Not RecruitingA Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007
Geographic Atrophy
Phase 32024-07-30
CompletedA Study of ANX009 in Adult Participants With Lupus Nephritis
Lupus Nephritis
Phase 12022-08-09
CompletedDose Study of ANX1502 in Healthy Volunteers
Healthy
Phase 12022-06-27
CompletedSingle Ascending Dose Study of ANX105
Healthy
Phase 12022-02-28
CompletedSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hem
Warm Autoimmune Hemolytic Anemia (wAIHA)
Phase 22021-11-10
CompletedA Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic
Geographic Atrophy
Phase 22021-02-26
CompletedStudy of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis
Phase 22021-01-15
CompletedEfficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome
Guillain-Barre Syndrome
Phase 32020-12-17
CompletedA Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)
Safety and Tolerability in Healthy Volunteers
Phase 12020-10-30
CompletedAn Open Label Study of ANX005 in Subjects With, or at Risk for, Manifest Huntington's Disease
Huntington Disease
Phase 22020-08-17
CompletedA Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)
Guillain-Barré Syndrome
Phase 12020-01-29
CompletedStudy of ANX007 in Participants With Primary Open-angle Glaucoma
Open Angle Glaucoma
Phase 12018-07-25
CompletedSingle-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma
Open-angle Glaucoma
Phase 12018-03-23
TerminatedSingle Dose Study of ANX005 in Healthy Volunteers
Safety and Tolerability in Healthy Volunteers
Phase 12016-12-01